Subscribe

Business

Evaluating the Benefits and Cost of the Sodium-Glucose Cotransporter 2 Inhibitors
Saving Money Is Not Always the Objective
Comparing Cost and Utilization of 2 Therapies for Metastatic Castration-Resistant Prostate Cancer
The Rationale for Comparing the Costs of Competing Treatment Options in Oncology
Challenges Surrounding the New Biosimilars Landscape
Adherence to Antihyperglycemic Treatment Regimen Also Reduces Overall Costs
Opioid-Induced Constipation Associated with Considerable Economic Burden
A Call to Action to Address Burden of Unintended Pregnancies in Plans’ Benefit Design
Is It Time for Risk-Sharing Contracts In Specialty Pharmacy?
Real-World Consequences of the 2013 ACC/AHA Cholesterol Guidelines for the Prevention of Cardiovascular Disease
Page 7 of 15
Results 61 - 70 of 143
Copyright © Engage Healthcare Communications, LLC. All rights reserved.